Medical News

RSS

Omthera to fund Epanova Phase 3 development with $33.9 million in Series B funding

Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that it has raised $33.9 million in a Series B funding round, led by new investor, New Enterprise Associates ("NEA"), one of the world's leading venture capital firms. Existing investor, Sofinnova Partners, also participated in the financing.

14 Mar 2011

Waivers continue to be flashpoints in health overhaul's implementation

More than 1,040 waiver requests have been approved so far by the Department of Health and Human Services regarding so-called "mini-med" plans. But the perplexing question appears to be how HHS will handle the requests in 2012 and 2013, before a major provision of the health law takes effect. In addition, anticipation continues to mount in regard to the upcoming release of ACO regs.

14 Mar 2011

Bonding with mom develops over first few weeks of life in rodent pups

For rodent pups, bonding with mom isn't hard-wired in the womb. It develops over the first few weeks of life, which is achieved by their maturing sense of smell, possibly allowing these mammals a survival advantage by learning to identify mother, siblings, and home.

14 Mar 2011

Medtronic launches Contour 3D Annuloplasty Ring for treatment of tricuspid valve disease

Medtronic, Inc. today announced the global launch of a new tricuspid ring for the treatment of tricuspid valve disease. Called the Contour 3D™ Annuloplasty Ring, the device is designed to restore normal valve function by remodeling the natural valve's shape and size. The Contour 3D Ring is approved for use in the U.S., Europe and several other countries.

14 Mar 2011

Maricom opens third office in Lutherville

Maricom Systems, Inc. continues its expansion and growth as it announced today the opening of the company's third office in Lutherville, Maryland. The new location will support the company's Business Development and Healthcare IT sectors. Maricom's other locations are in Woodlawn, the corporate headquarters, and Annapolis Junction, the Office of Classified Programs.

14 Mar 2011

First stage of $22.5 million Manitoba EHR project goes live

IBM today announced the first stage of a $22.5 million project to create an electronic healthcare records (EHR) system for the province of Manitoba has gone live, providing clinicians with unprecedented access to their patients' lab results, dispensed drug records and immunization histories, in seconds.

14 Mar 2011

Hospice care often provides benefits for survivors, too

A pair of Chicago Sun-Times stories outline new research findings regarding hospice care. Meanwhile, an Arizona lawmaker pushes to restore hospice care to the category of Medicaid-covered services, arguing that the care is not only better, but more cost-effective.

14 Mar 2011

How male puberty begins

Scientists from Monash University have uncovered a new understanding of how male puberty begins.

14 Mar 2011

Main Line Health implements eClinicalWorks comprehensive EHR solution

eClinicalWorks®, a market leader in ambulatory clinical systems, today announced that Main Line Health, a non-profit health system serving the greater Philadelphia region, is implementing eClinicalWorks comprehensive electronic health records (EHR) solution, and also making assistance available to its affiliated physicians who desire to use the eClinicalWorks EHR.

14 Mar 2011

Public opinion turns political dynamics of health reform

It appears that the public is still not embracing the new federal health law to the extent Democrats had hoped. As a result, Politico reports that Republican candidates for President and Congress may talk about the measure more than some Democrats — except, of course, when Democrats praise former Mass. Governor Mitt Romney for signing his home state's law.

14 Mar 2011

Indium oxine in development at Positron's Crown Point facility

Positron Corporation a molecular imaging company announced today that it is developing indium oxine, a radiopharmaceutical widely used for the radiolabeling of blood elements. This project signifies Positron's entrance into direct radiopharmaceutical manufacturing and sales; indium oxine is the first new product in development at Positron's research, development and manufacturing facility in Crown Point, Indiana.

14 Mar 2011

Majority of Americans fall short of vitamin D

Well-known for its role in keeping bones strong, vitamin D is now being hailed for so much more – from normal muscle function to a healthy immune system. Yet despite the growing research on the power of vitamin D, seven out of 10 Americans still fall short of the recommended vitamin D in their diets each day, according to the recent Dietary Guidelines Committee Advisory report.

14 Mar 2011

Study provides insight into aging immune system

A study featured on the cover of the March 15 Journal of Immunology is providing insight into why the elderly are so vulnerable to pneumonia and other bacterial infections.

14 Mar 2011

Viewpoints: Sebelius, Harkin, Wyden, King, Altman, Butler weigh in on health reform law

Early signs show that, after years of decline, the number of small businesses offering coverage to employees is increasing. Perhaps less widely recognized, but no less significant, has been the way the law is demanding transparency and accountability from the insurance industry to bring down premiums.

14 Mar 2011

HemaCare reports $7.0 million revenue for fourth quarter 2010

HemaCare Corporation announced today that the Company generated fourth quarter revenue of $7.0 million and a net loss of $197,000, or $0.02/share, compared to fourth quarter 2009 revenue of $8.2 million and net income of $195,000, or $0.02/share.

14 Mar 2011

Dehaier Medical enters distribution agreement with Shanghai Haopu for eVent's inspiration ventilators

Dehaier Medical Systems Ltd., an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it has signed a distribution agreement with Shanghai Haopu Medical Instruments Co. Ltd. to become a regional distributor of eVent Medical's inspiration ventilator in the Chinese market.

14 Mar 2011

Positive results from azide drug-loaded Emulsiphan preclinical toxicity study

Cornerstone Pharmaceuticals, Inc., a leader in cancer metabolism-based therapeutics, today announced encouraging results of a preclinical toxicity study of azide drug-loaded Emulsiphan nano emulsions conducted with the National Cancer Institute (NCI) under a Collaboration Agreement. Emulsiphan is Cornerstone's proprietary nanoparticle drug delivery system.

14 Mar 2011

Canon Digital Radiography Systems installed across multiple hospitals in Mexico

Broadening the Company's international reach, Canon U.S.A., Inc., a leader in digital imaging, today announced the installation of 178 digital radiography systems integrated with Canon brand CXDI-50G and CXDI-55G Digital Radiography Systems in various hospitals throughout Mexico through its local distributors, including Casa Plarre S.A. de C.V., helping to reaffirm Canon's commitment to provide quality medical equipment to help facilitate better patient care.

14 Mar 2011

Biodel selects BIOD-105, BIOD-107 recombinant human insulin formulations for clinical testing, development

Biodel Inc. announced today that it has selected two new formulations of recombinant human insulin for clinical testing and is accelerating clinical development plans of these mealtime insulin drug candidates. The new formulations, BIOD-105 and BIOD-107, are designed to result in more rapid insulin action compared to currently marketed meal time insulin analogs while maintaining an injection site tolerability profile comparable to currently marketed insulins.

14 Mar 2011

KAI initiates enrollment in KAI-4169 Phase 2 study for secondary hyperparathyroidism

KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).

14 Mar 2011